To further test the potential of sfrp3 as tumour suppressor in the presence of genetic changes that provide a sensitised background, we performed a crossed Sfrp3−/− mice with the MMTV-Neu (MMTV-Erbb2), which produced tumours classified as human luminal type carcinomas30. The gene discussed is ERBB2; the disease is neoplasm.